Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
FDA Oncology Update
FDA Oncology Update
FDA News - April 2017: Additional Items
Read More
FDA Oncology Update
FDA News - April 2017
Read More
FDA Oncology Update
FDA News - January 2017
Read More
FDA Oncology Update
FDA Approves Rucaparib and Companion Diagnostic for Patients with Advanced Ovarian Cancer
Read More
FDA Oncology Update
Daratumumab Combination Approved for Multiple Myeloma
Read More
Online First
FDA Updates
Sustol, First Extended-Release 5-HT3 Approved for the Prevention of CINV
Read More
Online First
FDA Updates
Cabometyx Receives FDA Approval for Advanced Renal-Cell Carcinoma
Read More
Online First
FDA Updates
Olaratumab Approved for Use with Doxorubicin in Adults with Advanced Soft-Tissue Sarcoma
Read More
Online First
FDA Updates
Atezolizumab First PD-L1 Inhibitor Approved for the Treatment of Patients with Metastatic NSCLC
Read More
FDA Oncology Update
Pembrolizumab Approved for Patients with Head and Neck Cancer
Read More
6
7
8
9
10
11
12
Page 9 of 13
Results 81 - 90 of 121